Coversyl (Perindopril) Dosing
For hypertension, start with perindopril 4 mg once daily in most adults, which can be increased to 8 mg once daily if needed; reduce to 2 mg once daily in patients with creatinine clearance <30 mL/min or elderly patients, and use 4 mg once daily for moderate renal impairment (CrCl 30-60 mL/min). 1, 2
Hypertension Dosing
Standard Adult Dosing
- Initial dose: 4 mg once daily
- Maintenance/Maximum: 4-8 mg once daily
- Timing: Take at any convenient time to establish a habitual pattern and improve adherence 3
The 2024 ESC guidelines recommend ACE inhibitors like perindopril as first-line therapy for hypertension, preferably combined with a dihydropyridine calcium channel blocker or thiazide diuretic 3. Fixed-dose combinations are preferred when combination therapy is needed 3.
Renal Impairment Adjustments
Critical dosing modifications are required based on kidney function:
- Severe renal impairment (CrCl <30 mL/min): 2 mg once daily 1, 2
- Moderate renal impairment (CrCl 30-60 mL/min): 4 mg once daily 1, 2
- Mild renal impairment or normal function: 4-8 mg once daily 1
The pharmacokinetic data shows perindoprilat (active metabolite) accumulates significantly in renal impairment, with accumulation ratios of 1.81 in mild renal failure versus 5.35 in severe renal failure 1. Despite this accumulation, the drug remains well-tolerated and does not worsen renal function 1, 2.
Elderly Patients
- Initial dose: 2 mg once daily
- Blood pressure reductions are greater in elderly patients due to pharmacokinetic differences, necessitating dose reduction 4
- Continue treatment lifelong, even beyond age 85, if well tolerated 3
Heart Failure Post-Myocardial Infarction
For heart failure following MI, use 8 mg once daily for optimal myocardial remodeling suppression and improved left ventricular function. 5
A 12-month study demonstrated that 8 mg daily produced superior outcomes compared to 4 mg daily, including:
- Better suppression of myocardial remodeling
- Improved left ventricular systolic function
- Lower NT-proBNP levels
- Reduced myocardial energy expenditure 5
Beta-blockers should be combined with perindopril when there are compelling indications such as post-MI or heart failure with reduced ejection fraction 3.
Blood Pressure Targets
Target systolic BP of 120-129 mmHg in most adults to reduce cardiovascular risk, provided treatment is well tolerated 3. If this target cannot be achieved due to poor tolerance, use the "as low as reasonably achievable" (ALARA) principle 3.
Common Pitfalls to Avoid
- Do not combine perindopril with ARBs - combining two RAS blockers is not recommended 3
- Monitor for hyperkalemia in renal impairment, though studies show kalemia remains stable (4.4 to 4.7 mmol/L) 2
- Dose reduction is mandatory in renal impairment - failure to adjust can lead to excessive drug accumulation 1
- Do not discontinue in elderly patients unless poorly tolerated - maintain lifelong treatment 3
Fixed-Dose Combinations
When combination therapy is needed:
- Perindopril 4 mg + Amlodipine 5 mg (can increase to 10/10 mg) 6, 7
- Perindopril 4 mg + Indapamide 1.25 mg 7
These combinations achieve blood pressure control in approximately 71-93% of patients with low rates of side effects including cough and pedal edema 7, 6.